Valence Labs Research
Ipamorelin
Growth Hormone Secretagogue Research Peptide
- Compound
- Ipamorelin
- Category
- Research Peptide
- Available Variant
- 5mg
- Research Status
- Research Use Only
Overview
Ipamorelin is a pentapeptide growth hormone secretagogue studied in GHRP and ghrelin-receptor-family signaling research.
Research interest includes pituitary GH-release signaling, receptor selectivity, and structure–activity relationships. Animal and in-vitro findings should not be treated as equivalent to established human evidence.
Research Areas
GHRP / Ghrelin-Receptor Signaling
Ipamorelin is studied as a growth hormone secretagogue in GHRP and ghrelin-receptor-family signaling research.
Pituitary GH-Release Signaling
Research examines how this pentapeptide relates to pituitary GH-release signaling in experimental models.
Receptor Selectivity & Structure–Activity Research
Published work has addressed receptor selectivity and structure–activity questions for this secretagogue.
How It Is Being Studied
Ipamorelin has been examined in experimental, animal, and related laboratory models. Findings from those settings should not be interpreted as established human treatment outcomes.
This page summarizes published research contexts and does not provide administration, dosing, or performance-related guidance.
Specifications
Catalog details for this product.
- Product Name
- Ipamorelin
- Category
- Research Peptide
- Variant
- 5mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Documentation will appear here as records are published.
References
- Raun et al. — Ipamorelin, the first selective growth hormone secretagogue
European journal of endocrinology
Available Product
Ipamorelin
5mg